drugset / Trial / NCT03866928

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

NCT03866928

Phase 1 Completed 14 enrolled Biocodex
NaSingle-groupOpen-labelBasic science

Summary

This is a monocentric open label study to assess the PK parameters of stiripentol and its metabolites (if any are detected) after multiple oral doses in 14 healthy male subjects.

Timeline

Start
2019-02-12
Primary completion
2019-04-05
Completion
2019-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Stiripentol Small molecule 1500 mg Oral

Indications

No indication recorded.